Treatment for cancer is undergoing a renaissance. However, the “financial toxicity” of cancer treatment for US patients and their families is a growing concern.1 Financial distress among patients with cancer includes high out-of-pocket (OOP) spending relative to income and assets, loss of work, and significant household debt. Financial distress is associated with growing reports of delayed initiation of treatment, limited patient adherence, and abandonment of recommended treatment, which erodes the effectiveness of cancer treatment and even hastens death.
de Souza JA, Conti RM. Mitigating Financial Toxicity Among US Patients With Cancer. JAMA Oncol. 2017;3(6):765–766. doi:10.1001/jamaoncol.2016.4850
Customize your JAMA Network experience by selecting one or more topics from the list below.